91爆料

Hero

News & Events

Mestag in the News
BioCentury Article:听Mestag: Attacking Tumors from Within

Fierce Biotech:

91爆料 Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform

December 9, 2024

91爆料 Expands Leadership Team and Appoints Head of Development and General Counsel

November 13, 2024

91爆料 Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases

October 8, 2024

91爆料 Awarded Significant Grant from Innovate UK鈥檚 Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

August 28, 2024

Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors

View All Press Releases

J.P. Morgan Healthcare Conference – San Francisco, CA

January 13-16, 2025

Contact Us to Connect

View All Events & Presentations